Connection

Eric Rovner to Middle Aged

This is a "connection" page, showing publications Eric Rovner has written about Middle Aged.
Connection Strength

1.392
  1. Is it the Surgeon? A Re-examination of Mid-urethral Sling Complications. Urology. 2021 11; 157:269-273.
    View in: PubMed
    Score: 0.054
  2. Shortness of Breath Secondary to a Massive Bladder Diverticulum: A Unique Transvesical Repair. Urology. 2020 08; 142:e1-e3.
    View in: PubMed
    Score: 0.050
  3. Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials. Neurourol Urodyn. 2020 02; 39(2):744-753.
    View in: PubMed
    Score: 0.048
  4. One-year results with selective bladder denervation in women with refractory overactive bladder. Neurourol Urodyn. 2019 11; 38(8):2178-2184.
    View in: PubMed
    Score: 0.047
  5. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019 05; 201(5):967-972.
    View in: PubMed
    Score: 0.046
  6. Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon. Neurourol Urodyn. 2018 01; 37(1):440-448.
    View in: PubMed
    Score: 0.041
  7. Outcomes of treatment of stress urinary incontinence associated with female urethral diverticula: A selective approach. Neurourol Urodyn. 2018 01; 37(1):478-484.
    View in: PubMed
    Score: 0.040
  8. Transvaginal approach to distal ureterectomy in an obstructed remnant. Int Urogynecol J. 2017 Sep; 28(9):1431-1433.
    View in: PubMed
    Score: 0.040
  9. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study. Low Urin Tract Symptoms. 2018 Sep; 10(3):221-230.
    View in: PubMed
    Score: 0.040
  10. Analysis of Complications of Pelvic Mesh Excision Surgery Using the Clavien-Dindo Classification System. J Urol. 2017 09; 198(3):638-643.
    View in: PubMed
    Score: 0.040
  11. A case of uncomplicated urinary myiasis in a healthy female. BMJ Case Rep. 2016 Jun 23; 2016.
    View in: PubMed
    Score: 0.038
  12. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol. 2016 Sep; 196(3):801-8.
    View in: PubMed
    Score: 0.038
  13. Female Urethral Diverticula in the Contemporary Era: Is the Classic Triad of the "3Ds" Still Relevant? Urology. 2016 Aug; 94:53-6.
    View in: PubMed
    Score: 0.037
  14. Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal. J Urol. 2016 Aug; 196(2):484-9.
    View in: PubMed
    Score: 0.037
  15. Simple vs complex urethral diverticulum: presentation and outcomes. Urology. 2014 Dec; 84(6):1516-9.
    View in: PubMed
    Score: 0.034
  16. Patient perception of transvaginal mesh and the media. Urology. 2014 Sep; 84(3):575-82.
    View in: PubMed
    Score: 0.033
  17. A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence. J Urol. 2013 Dec; 190(6):2243-50.
    View in: PubMed
    Score: 0.031
  18. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2013 Nov; 32(8):1109-15.
    View in: PubMed
    Score: 0.030
  19. Sling location in women with recurrent stress urinary incontinence following midurethral sling. Urology. 2012 Jan; 79(1):76-9.
    View in: PubMed
    Score: 0.027
  20. Transvaginal bladder neck closure with posterior urethral flap for devastated urethra. Urology. 2011 Jul; 78(1):208-12.
    View in: PubMed
    Score: 0.027
  21. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn. 2011 Apr; 30(4):556-62.
    View in: PubMed
    Score: 0.026
  22. Effect of A 7-F transurethral catheter on abdominal leak point pressure measurement in men with post-prostatectomy incontinence. Urology. 2011 May; 77(5):1188-93.
    View in: PubMed
    Score: 0.026
  23. Predicting for postoperative incontinence following sling incision. Int Urogynecol J. 2011 Jun; 22(6):665-9.
    View in: PubMed
    Score: 0.026
  24. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. J Urol. 2008 Sep; 180(3):1034-41.
    View in: PubMed
    Score: 0.022
  25. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93.
    View in: PubMed
    Score: 0.022
  26. Complications of anterior compartment vaginal surgery. Curr Urol Rep. 2007 Sep; 8(5):405-12.
    View in: PubMed
    Score: 0.020
  27. Trospium chloride: the European experience. Expert Opin Pharmacother. 2006 Jul; 7(10):1373-80.
    View in: PubMed
    Score: 0.019
  28. Female urethral strictures: successful management with long-term clean intermittent catheterization after urethral dilatation. BJU Int. 2006 Jul; 98(1):96-9.
    View in: PubMed
    Score: 0.019
  29. Long-term chronic complications from Stamey endoscopic bladder neck suspension: a case series. Int Urogynecol J Pelvic Floor Dysfunct. 2006 May; 17(3):290-4.
    View in: PubMed
    Score: 0.018
  30. Urodynamically defined stress urinary incontinence and bladder outlet obstruction coexist in women. J Urol. 2004 Feb; 171(2 Pt 1):757-60; discussion 760-1.
    View in: PubMed
    Score: 0.016
  31. Trospium chloride in the management of overactive bladder. Drugs. 2004; 64(21):2433-46.
    View in: PubMed
    Score: 0.016
  32. Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol. 2003 Jul; 170(1):82-6; discussion 86.
    View in: PubMed
    Score: 0.015
  33. Vaginal erosion after pubovaginal sling procedures using dermal allografts. J Urol. 2003 Jan; 169(1):286-7.
    View in: PubMed
    Score: 0.015
  34. Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. Eur Urol. 2002 Jan; 41(1):6-14.
    View in: PubMed
    Score: 0.014
  35. Severe urinary tract damage secondary to primary bladder neck obstruction in women. PLoS One. 2021; 16(3):e0248938.
    View in: PubMed
    Score: 0.013
  36. Significance of hematuria in patients with interstitial cystitis: review of radiographic and endoscopic findings. Urology. 2001 Feb; 57(2):262-5.
    View in: PubMed
    Score: 0.013
  37. Angiomyolipoma of the renal sinus: diagnosis by percutaneous biopsy. Urology. 2000 Feb; 55(2):286.
    View in: PubMed
    Score: 0.012
  38. Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE). Adv Ther. 2019 08; 36(8):1906-1921.
    View in: PubMed
    Score: 0.012
  39. Extraperitoneal laparoscopic urethropexy with Marlex mesh. Urology. 1999 May; 53(5):985-9.
    View in: PubMed
    Score: 0.011
  40. Images in clinical urology. Magnetic resonance imaging of a "saddle bag" urethral diverticulum. Urology. 1999 Apr; 53(4):818-9.
    View in: PubMed
    Score: 0.011
  41. Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder. J Urol. 2019 03; 201(3):573-580.
    View in: PubMed
    Score: 0.011
  42. Study design and outcomes measures: The influence of composite endpoints and other design variables on outcomes in a study of a novel device for stress urinary incontinence. Neurourol Urodyn. 2018 11; 37(8):2919-2927.
    View in: PubMed
    Score: 0.011
  43. Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon. Female Pelvic Med Reconstr Surg. 2018 May/Jun; 24(3):222-231.
    View in: PubMed
    Score: 0.011
  44. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol. 1997 Jul; 158(1):138-41; discussion 141-2.
    View in: PubMed
    Score: 0.010
  45. Regulation of transient receptor potential melastatin 4 channel by sarcoplasmic reticulum inositol trisphosphate receptors: Role in human detrusor smooth muscle function. Channels (Austin). 2017 Sep 03; 11(5):459-466.
    View in: PubMed
    Score: 0.010
  46. BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function. Am J Physiol Renal Physiol. 2016 05 15; 310(10):F994-9.
    View in: PubMed
    Score: 0.009
  47. Novel regulatory mechanism in human urinary bladder: central role of transient receptor potential melastatin 4 channels in detrusor smooth muscle function. Am J Physiol Cell Physiol. 2016 Apr 01; 310(7):C600-11.
    View in: PubMed
    Score: 0.009
  48. Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2016 06; 35(5):595-600.
    View in: PubMed
    Score: 0.009
  49. Functional link between muscarinic receptors and large-conductance Ca2+ -activated K+ channels in freshly isolated human detrusor smooth muscle cells. Pflugers Arch. 2015 Apr; 467(4):665-75.
    View in: PubMed
    Score: 0.008
  50. BRL37344, a ?3-adrenergic receptor agonist, decreases nerve-evoked contractions in human detrusor smooth muscle isolated strips: role of BK channels. Urology. 2013 Sep; 82(3):744.e1-7.
    View in: PubMed
    Score: 0.008
  51. Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels. PLoS One. 2013; 8(7):e68052.
    View in: PubMed
    Score: 0.008
  52. Single-channel biophysical and pharmacological characterizations of native human large-conductance calcium-activated potassium channels in freshly isolated detrusor smooth muscle cells. Pflugers Arch. 2013 Jul; 465(7):965-75.
    View in: PubMed
    Score: 0.007
  53. SK channel-selective opening by SKA-31 induces hyperpolarization and decreases contractility in human urinary bladder smooth muscle. Am J Physiol Regul Integr Comp Physiol. 2013 Jan 15; 304(2):R155-63.
    View in: PubMed
    Score: 0.007
  54. Constitutively active phosphodiesterase activity regulates urinary bladder smooth muscle function: critical role of KCa1.1 channel. Am J Physiol Renal Physiol. 2012 Nov 01; 303(9):F1300-6.
    View in: PubMed
    Score: 0.007
  55. Investigation of a Ca2+ channel a2d ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial. J Urol. 2012 Sep; 188(3):817-23.
    View in: PubMed
    Score: 0.007
  56. SK but not IK channels regulate human detrusor smooth muscle spontaneous and nerve-evoked contractions. Am J Physiol Renal Physiol. 2012 Aug 15; 303(4):F559-68.
    View in: PubMed
    Score: 0.007
  57. Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1599-608.
    View in: PubMed
    Score: 0.007
  58. Suppression of human detrusor smooth muscle excitability and contractility via pharmacological activation of large conductance Ca2+-activated K+ channels. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1632-41.
    View in: PubMed
    Score: 0.007
  59. Large-conductance voltage- and Ca2+-activated K+ channels regulate human detrusor smooth muscle function. Am J Physiol Cell Physiol. 2011 Oct; 301(4):C903-12.
    View in: PubMed
    Score: 0.007
  60. Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials. Drugs Aging. 2011 Feb 01; 28(2):151-60.
    View in: PubMed
    Score: 0.006
  61. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2010 Jan; 183(1):234-40.
    View in: PubMed
    Score: 0.006
  62. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010 May; 105(9):1276-82.
    View in: PubMed
    Score: 0.006
  63. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int. 2010 May; 105(9):1268-75.
    View in: PubMed
    Score: 0.006
  64. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology. 2009 Oct; 74(4):771-5.
    View in: PubMed
    Score: 0.006
  65. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009 Sep; 182(3):1055-61.
    View in: PubMed
    Score: 0.006
  66. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008 May; 179(5):1850-6.
    View in: PubMed
    Score: 0.005
  67. Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May; 71(5):839-43.
    View in: PubMed
    Score: 0.005
  68. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007 Feb; 177(2):556-60.
    View in: PubMed
    Score: 0.005
  69. MRI of endocervicosis: an unusual cause of clustered periurethral cystic masses involving the bladder. AJR Am J Roentgenol. 2007 Feb; 188(2):W147-9.
    View in: PubMed
    Score: 0.005
  70. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006 Nov 15; 296(19):2319-28.
    View in: PubMed
    Score: 0.005
  71. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology. 2006 Aug; 68(2):328-32.
    View in: PubMed
    Score: 0.005
  72. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. BJU Int. 2006 May; 97(5):1003-6.
    View in: PubMed
    Score: 0.005
  73. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006 Apr; 67(4):731-6; discussion 736.
    View in: PubMed
    Score: 0.005
  74. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health. 2005 Nov-Dec; 8 Suppl 1:S25-34.
    View in: PubMed
    Score: 0.005
  75. A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol. 2005 Jan; 192(1):66-73.
    View in: PubMed
    Score: 0.004
  76. Is urine methylhistamine a useful marker for interstitial cystitis? J Urol. 2004 Dec; 172(6 Pt 1):2256-60.
    View in: PubMed
    Score: 0.004
  77. Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis. Urology. 2003 May; 61(5):897-901.
    View in: PubMed
    Score: 0.004
  78. Continence mechanism based on a modified ileocecal valve. Tech Urol. 2000 Sep; 6(3):167-71.
    View in: PubMed
    Score: 0.003
  79. Artificial urinary sphincter for post-prostatectomy incontinence: impact of prior collagen injection on cost and clinical outcome. J Urol. 2000 Jan; 163(1):87-90.
    View in: PubMed
    Score: 0.003
  80. 4-Defect repair of grade 4 cystocele. J Urol. 1999 Feb; 161(2):587-94.
    View in: PubMed
    Score: 0.003
  81. Posthysterectomy vaginal cuff fistula: diagnosis and management of an unusual cause of "incontinence". Urology. 1998 Jul; 52(1):61-4; discussion 64-5.
    View in: PubMed
    Score: 0.003
  82. Vaginal evisceration. Urology. 1998 Jan; 51(1):128-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.